Accéder au contenu
Merck

[Use of inhaled beclomethasone dipropionate in adult asthma].

Presse medicale (Paris, France : 1983) (1992-10-03)
J C Guérin, M Pappo
RÉSUMÉ

Beclomethasone dipropionate has now been used for more than 10 years during which our knowledge of how to use inhaled corticosteroids has gradually improved: high dose initial treatment followed by progressive reduction down to the minimum effective dosage; administration in 2 daily doses when the asthma is stable and 4 daily doses in case of instability; mild and transient undesirable effects, often minimized by a correct use of the inhaler; effectiveness assessed from bronchial hyper-reactivity and respiratory function tests, reduction or avoidance of oral corticosteroid therapy, or results of association with other treatments, and in particular bronchodilators. When exactly should inhaled corticosteroid therapy should be started and how long should it be pursued are controversial points, but an early and prolonged treatment must probably be recommended.

MATÉRIAUX
Référence du produit
Marque
Description du produit

USP
Beclomethasone dipropionate, United States Pharmacopeia (USP) Reference Standard
Supelco
Beclomethasone dipropionate, analytical standard, for drug analysis
Beclometasone dipropionate for system suitability, European Pharmacopoeia (EP) Reference Standard
Beclomethasone dipropionate, anhydrous, European Pharmacopoeia (EP) Reference Standard
Beclometasone dipropionate for peak identification, European Pharmacopoeia (EP) Reference Standard